Proteostasis Therapeutics, Inc. (PTI) Technical And Fundamental Data On The Rise

Facebook
Twitter
WhatsApp

Proteostasis Therapeutics, Inc. (PTI) has seen some recent activity in the stock market and its shares were last quoted at $1.7600 yesterday. People are starting to take notice of PTI as the shares traded as high as $1.8400 and as low as $1.4500 in the last market trading day.

Proteostasis Therapeutics, Inc. (PTI) average trading volume is 1.11M. However, in the last market trading day Proteostasis Therapeutics, Inc. (PTI) traded 3,814,681 shares. The First downside support level on PTI is $1.57 and the First upside resistance level on PTI is $2.03. PTI 50 day moving average is $1.4266 and PTI 200day moving average is $1.4829.

Proteostasis Therapeutics, Inc. (PTI) recent performance has been indicated by the recent movement in PTI shares. PTI has performed 31.34% over the past month, PTI has performed 19.73% over the past quarter and PTI has shown 124.09% over the past 1 year. Proteostasis Therapeutics, Inc. (PTI) has a 52 week range of $0.6100 to $4.7200. Proteostasis Therapeutics, Inc. (PTI) is trading 188.52% from its 52 week low and -62.71% from its 52 week high. Proteostasis Therapeutics, Inc. (PTI) is displaying a 5.98% short float displaying the amount short in the float.

PTI has 52.15M shares outstanding and 42.37M shares in the float. Proteostasis Therapeutics, Inc. (PTI) at this time has a market cap of $90.52M and income of -54.60M. The EPS next quarter for PTI is -0.21 and forecasted EPS next year is 4.30%. The market cap of Proteostasis Therapeutics, Inc. (PTI) at $90.52M represents how many People own shares of PTI and is calculated off the last price ($1.7600) of PTI and the amount of shares outstanding (52.15M) with Proteostasis Therapeutics, Inc. (PTI).

Proteostasis Therapeutics, Inc. (PTI) has total cash (mrq) of 57.1M, total cash per share (mrq) of 1.1, total debt of PTI stands at 14.02M and total debt/equity (mrq) is 26.38. . Proteostasis Therapeutics, Inc. (PTI) operating cash flow (ttm) is -53.34M, PTI leveraged free cash flow (ttm) is -32.44M.

PTI is trading 25.49% above (bullish) its SMA20, 23.15% above (bullish) its SMA50 and 10.19% above (bullish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...